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•Understand how the activation of glycolysis Warburg effect works in cancer cells. 
•Research the mechanisms through which this metabolic alteration develop.  
•Analyze which are the practical approaches of the Warburg effect. 
 
AIMS 
 
 
 
 However, cancer cells increase the rate of 
glycolysis in presence of O2 Warburg 
effect . 
 
•The Warburg effect is essential for cancer 
cells given that it rapidly provides them 
with energy as well as building blocks, 
required for a quick cell proliferation. 
• It’s due to mitochondrial defects, 
hypoxia, oncogenic signals and altered 
metabolic enzymes. 
•Because of Warburg effect, cancer cells 
increase their glucose demand. This fact is 
the basis for positron tomography with 
18-fluorodeoxyglucose FDG-PET Figure 
1.  
•Therefore, the inhibition of glycolysis is a 
target for  anticancer therapy Figure 2. 
 
 
 
CANCER CELL METABOLISM 
OXPHOS 36 ATP is more 
efficient than glycolysis 2 ATP 
 
CONCLUSIONS 
Figure 2. Glycolytic and pentose 
phosphate pathway. The red arrows 
indicate which are the agents that inhibit 
glycolysis.  
•Cancer cells depend on glycolysis to generate ATP and survive. That’s why they increase 
the rate of glycolysis even in the presence of oxygen.   
•The Warbug effect is a multifactorial process. 
•Based on the Warburg effect, an imaging method of diagnostic has been develop. 
•Although drugs that inhibit glycolysis are ineffective in vivo, they can be used in 
combination with other antitumoral agents. 
 
Figure 1. Image 
obtained on a 
hybrid PETCT  
computerized 
tomography. The 
tumor T is 
highlighted in the 
image.  
